COLCHICINA LIRCA 1 mg compresse clinical trials

Single-blinded randomized investigator-initiated controlled trial to assess the efficacy of colchicine to treat patients with cardiomyopathy with myocarditis (chronic inflammatory cardiomyopathy) – Trial and Registry to study the role of genotype environment interaction in Chronic myocarditis and inflammatory cardiomyopathies with ventricular pro-arrhythmic and heart failure phenotypes (PNRR-MAD-2022-12376225)

This study is looking at whether a medicine called colchicine can help people with an inflammatory heart condition. It aims to see if the medicine can prevent the condition from getting worse and help improve heart health over six months.